Functional expression of the damage-associated molecular pattern receptor P2X7 on canine kidney epithelial cells

Veterinary Immunology and Immunopathology

Volumn 150, Issue 3-4, 2012, Pages 228-233

  Jalilian, Iman ^a,b,e   Spildrejorde, Mari ^a,b   Seavers, Aine ^c   Curtis, Belinda L ^d   McArthur, Jason D ^a,b   Sluyter, Ronald ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c Oak Flats Veterinary Clinic   (Australia)

^d Albion Park Veterinary Hospital   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cytokine; Dog; Epithelial cell; Inflammasome; Purinergic receptor; TLR4

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FLOW CYTOMETRY; IMMUNOBLOTTING; KIDNEY EPITHELIUM; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE; DOGS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INFLAMMASOMES; KIDNEY; RECEPTORS, PURINERGIC P2X7; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

CANIS FAMILIARIS;

EID: 84868458461     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.09.040     Document Type: Article

References (40)

1. Arulkumaran N., Unwin R.J., Tam F.W. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 2011, 20:897-915.
2. Asahina Y., Yoshioka N., Kano R., Moritomo T., Hasegawa A. Full-length cDNA cloning of Toll-like receptor 4 in dogs and cats. Vet. Immunol. Immunopathol. 2003, 96:159-167.
3. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
4. Bours M.J., Dagnelie P.C., Giuliani A.L., Wesselius A., Di Virgilio F. P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front. Biosci. (Schol. Ed.) 2011, 3:1443-1456.
5. Bradley H.J., Browne L.E., Yang W., Jiang L.H. Pharmacological properties of the rhesus macaque monkey P2X7 receptor. Br. J. Pharmacol. 2011, 164:743-754.
6. Burgener I.A., Jungi T.W. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008, 124:184-191.
7. Cesaro A., Brest P., Hofman V., Hébuterne X., Wildman S., Ferrua B., Marchetti S., Doglio A., Vouret-Craviari V., Galland F., Naquet P., Mograbi B., Unwin R., Hofman P. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G32-G42.
8. Chamizo C., Rubio J.M., Moreno J., Alvar J. Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR. Vet. Immunol. Immunopathol. 2001, 83:191-202.
9. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
10. Constantinescu P., Wang B., Kovacevic K., Jalilian I., Bosman G.J., Wiley J.S., Sluyter R. P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells. Biochim. Biophys. Acta 2010, 1798:1797-1804.
11. Darville T.L.W.-S., Cruz C., Sater A.A., Andrews C.W., Ojcius D.M. Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice. J. Immunol. 2007, 179:3707-3714.
12. 7 and the inflammasome. Trends Pharmacol. Sci. 2007, 28:465-472.
13. Donnelly-Roberts D.L., Namovic M.T., Han P., Jarvis M.F. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 2009, 157:1203-1214.
14. Feldenberg L.R., Thevananther S., del Rio M., de Leon M., Devarajan P. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am. J. Physiol. 1999, 276:F837-F846.
15. Gadeock S., Tran J.N., Georgiou J.G., Jalilian I., Taylor R.M., Wiley J.S., Sluyter R. TGF-β1 prevents up-regulation of the P2X7 receptor by IFN-γ and LPS in leukemic THP-1 monocytes. Biochim. Biophys. Acta 2010, 1798:2058-2066.
16. Gadeock S., Pupovac A., Sluyter V., Spildrejorde M., Sluyter R. P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells. Purinergic Signal. 2012, 10.1007/s11302-012-9320-9.
17. Goncalves R.G., Gabrich L., Rosário A., Takiya C.M., Ferreira M.L., Chiarini L.B., Persechini P.M., Coutinho-Silva R., Leite M. The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int. 2006, 70:1599-1606.
18. Gröne A., Fonfara S., Baumgärtner W. Cell type-dependent cytokine expression after canine distemper virus infection. Viral Immunol. 2002, 15:493-505.
19. Insel P.A., Ostrom R.S., Zambon A.C., Hughes R.J., Balboa M.A., Shehnaz D., Gregorian C., Torres B., Firestein B.L., Xing M., Post S. P2Y receptors of MDCK cells: epithelial cell regulation by extracellular nucleotides. Clin. Exp. Pharmacol. Physiol. 2001, 28:351-354.
20. Jalilian I., Peranec M., Curtis B.L., Seavers A., Spildrejorde M., Sluyter V., Sluyter R. Activation of the damage-associated molecular pattern receptor P2X7 induces interleukin-1β release from canine monocytes. Vet. Immunol. Immunopathol. 2012, 149:86-91.
21. Jarvis M.F., Khakh B.S. ATP-gated P2X cation channels. Neuropharmacology 2009, 56:208-215.
22. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
23. Liévin-Le Moal V., Beau I., Rougeaux C., Kansau I., Fabrega S., Brice C., Korotkova N., Moseley S.L., Servin A.L. Apical expression of human full-length hCEACAM1-4L protein renders the Madin Darby canine kidney cells responsive to lipopolysaccharide leading to TLR4-dependent Erk1/2 and p38 MAPK signalling. Cell. Microbiol. 2011, 13:764-785.
24. Maccoux L.J., Salway F., Day P.J.R., Clements D.N. Expression profiling of select cytokines in canine osteoarthritis tissues. Vet. Immunol. Immunopathol. 2007, 118:59-67.
25. Mehta V.B., Hart J., Wewers M.D. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 2001, 276:3820-3826.
26. Michel A.D., Chessell I.P., Humphrey P.P. Ionic effects on human recombinant P2X7 receptor function. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 359:102-109.
27. Ostrom R.S., Gregorian C., Insel P.A. Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J. Biol. Chem. 2000, 275:11735-11739.
28. 7 receptor by a novel protein tyrosine kinase antagonist. Biochem. Biophys. Res. Commun. 2008, 365:515-520.
29. Shigeoka A.A., Mueller J.L., Kambo A., Mathison J.C., King A.J., Hall W.F., da Silva Correia J., Ulevitch R.J., Hoffman H.M., McKay D.B. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J. Immunol. 2010, 185:6277-6285.
30. 7 receptor impairs ATP-induced IL-1β release from human monocytes. J. Immunol. 2004, 172:3399-3405.
31. 7 receptor: greatly increased function compared to human erythrocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2090-R2098.
32. Sluyter R., Stokes L. Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 2011, 5:41-54.
33. 7 receptors. J. Biol. Chem. 2001, 276:125-132.
34. 7 receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types. Purinergic Signal. 2009, 5:385-394.
35. Sun J., Fegan P.E., Desai A.S., Madara J.L., Hobert M.E. Flagellin-induced tolerance of the Toll-like receptor 5 signaling pathway in polarized intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G767-G778.
36. Swerdlow M.P., Kennedy D.R., Kennedy J.S., Washabau R.J., Henthorn P.S., Moore P.F., Carding S.R., Felsburg P.J. Expression and function of TLR2, TLR4, and Nod2 in primary canine colonic epithelial cells. Vet. Immunol. Immunopathol. 2006, 114:313-319.
37. Taylor S.R., Turner C.M., Elliott J.I., McDaid J., Hewitt R., Smith J., Pickering M.C., Whitehouse D.L., Cook H.T., Burnstock G., Pusey C.D., Unwin R.J., Tam F.W. P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 2009, 20:1275-1281.
38. Turner C.M., Tam F.W., Lai P.C., Tarzi R.M., Burnstock G., Pusey C.D., Cook H.T., Unwin R.J. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol. Dial. Transplant. 2007, 22:386-395.
39. Wiley J.S., Sluyter R., Gu B.J., Stokes L., Fuller S.J. The human P2X7 receptor and its role in innate immunity. Tissue Antigens 2011, 78:321-332.
40. Wu H., Chen G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., Alexander S.I., Sharland A.F., Chadban S.J. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 2007, 117:2847-2859.